2-(Fluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-pyridine is used to prepare 8-substituted isoquinoline derivatives as IKKβ kinase inhibitors for treating and/or preventing articular rheumatism, acute or chronic inflammation, or cancer in mammals.